HER2 Specific CAR T Cell clinical trials

HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma

This study is testing a new immune cell therapy for children aged 1-21 with a brain tumour called ependymoma, if it has recurred or grown. It aims to see if it's safe, how well it works, and if it can be given in different hospitals across the UK.